Orphanet: Etude multicentrique, en ouvert, à un seul bras et dose unique évaluant la sécurité d_emploi d_un traitement substitutif mensuel par le facteur XIII recombinant rFXIII chez des patients présentant un déficit congénital en facteur XIII Etude d_extension de l_essai F13CD 1725 Phase III
x

Search for a clinical trial

* (*) mandatory field

A Multi-Centre, Open-Label, Single-Arm, and Multiple Dosing Trial on Safety of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Subjects with Congenital Factor XIII Deficiency (Safety Extension Trial to F13CD-1725) (Phase III) - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Novo nordisk a/s
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Marie DREYFUS
  • Service d'Hmatologie
  • CHU Paris-Sud - Hpital de Bictre
  • 78 rue du Gnral Leclerc
  • 94270 LE KREMLIN-BICTRE
  • FRANCE
  • More information
  • Phone  : 33 (0)1 45 21 28 40
  • Fax  : 33 (0)1 45 21 28 47
  • Website
Last update: November 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.